{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T07:49:40Z","timestamp":1758786580943,"version":"3.44.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"Background<\/jats:title>Optimal medical therapy (OMT) is recommended in patients with coronary artery disease (CAD) following percutaneous coronary intervention (PCI) to enhance the clinical outcomes and support secondary prevention. However, real-world data on OMT prescription practices in the United Arab Emirates (UAE) remain limited. This study aimed to evaluate the prevalence and determinants of OMT prescription at hospital discharge in a UAE tertiary care setting.<\/jats:p><\/jats:sec>Methods<\/jats:title>This retrospective observational study included 103 consecutive patients who underwent PCI between January 2021 and June 2023 at a tertiary academic hospital in the UAE. Demographic and clinical data, including comorbidities and discharge medications, were collected from electronic medical records. OMT was defined as the concurrent prescription of aspirin, a P2Y12 inhibitor, statin, \u03b2<\/jats:italic>-blocker, and either an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB). Patients were stratified into OMT and non-OMT groups. Categorical variables were compared using the chi-square test or Fisher's exact test, as appropriate, while non-normally distributed continuous variables were analyzed using the Mann\u2013Whitney U<\/jats:italic>-test. Multivariate logistic regression was used to identify factors independently associated with OMT prescription at discharge.<\/jats:p><\/jats:sec>Results<\/jats:title>Among the 103 patients, the median age was 49.0 years [interquartile range (IQR): 44.3\u201354.1], with a predominance of males (93.2%) and non-Arabs (74.8%). OMT was prescribed at discharge in 39 patients (37.9%). Multivariate analysis revealed that diabetes (adjusted odds ratio [aOR]\u2009=\u20093.86, 95% confidence interval [CI]: 1.42\u201310.52, p<\/jats:italic>\u2009=\u20090.01), and hypertension (aOR\u2009=\u20095.99, 95% CI: 2.04\u201317.60, p<\/jats:italic>\u2009=\u20090.001) were significantly associated with higher odds of OMT prescription. In contrast, age &gt;50 years (aOR\u2009=\u20090.23, 95% CI: 0.08\u20130.65, p<\/jats:italic>\u2009=\u20090.01) and the presence of acute heart failure (aOR\u2009=\u20090.06, 95% CI: 0.01\u20130.60, p<\/jats:italic>\u2009=\u20090.02) were associated with lower odds.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>The rate of OMT prescriptions at discharge was comparable to international studies, though suboptimal. Diabetes and hypertension were positive predictors, while advanced age, and acute heart failure were negative predictors of OMT prescription. Multicenter studies with larger sample size would be needed to get more details. These findings suggest a need for targeted interventions to improve adherence to guideline-directed therapy. Future multicenter studies with larger sample sizes are warranted to validate these observations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1522216","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:06:56Z","timestamp":1758719216000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in prescribing optimal medical therapy at discharge following percutaneous coronary intervention in a tertiary care hospital in the UAE"],"prefix":"10.3389","volume":"12","author":[{"given":"Maryam","family":"Charehjoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seeba","family":"Zachariah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Ghannem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firas","family":"Alani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"McKeirnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990\u20132022","volume":"82","author":"Mensah","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"B2","first-page":"e006488","article-title":"Cardiovascular and noncardiovascular death after percutaneous coronary intervention","volume":"11","author":"Brener","year":"2018","journal-title":"Circ: Cardiovasc Interventions"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.athoracsur.2006.10.046","article-title":"Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery","volume":"83","author":"Goyal","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.109.913111","article-title":"The bypass angioplasty revascularization investigation 2 diabetes randomized trial of different treatment strategies in type 2 diabetes Mellitus with stable ischemic heart disease","volume":"120","author":"Chaitman","year":"2009","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.109.911669","article-title":"Ten-Year follow-up survival of the medicine, angioplasty, or surgery study (MASS II)","volume":"122","author":"Hueb","year":"2010","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/CIRCULATIONAHA.114.013042","article-title":"Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting","volume":"131","author":"Iqbal","year":"2015","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(11)61215-4","article-title":"Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE study): a prospective epidemiological survey","volume":"378","author":"Yusuf","year":"2011","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1177\/2047487318825350","article-title":"Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"B12","doi-asserted-by":"crossref","first-page":"e005455","DOI":"10.1161\/CIRCOUTCOMES.118.005455","article-title":"Medical therapy utilization and long-term outcomes following percutaneous coronary intervention","volume":"12","author":"Xie","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.cjco.2020.04.002","article-title":"Update to evidence-based secondary prevention strategies after acute coronary syndrome","volume":"2","author":"Fitchett","year":"2020","journal-title":"CJC Open"},{"key":"B14","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1136\/oem.2005.020354","article-title":"Long driving time is associated with haematological markers of increased cardiovascular risk in taxi drivers","volume":"62","author":"Chen","year":"2005","journal-title":"Occup Environ Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/ehjcvp\/pvy005","article-title":"Trends in optimal medical therapy prescription and mortality after admission for acute coronary syndrome: a 9-year experience in a real-world setting","volume":"4","author":"Hoedemaker","year":"2018","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"B16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s40256-020-00427-9","article-title":"Optimal medical therapy prescription in patients with acute coronary syndrome in The Netherlands: a multicenter pilot registry","volume":"21","author":"Hoedemaker","year":"2021","journal-title":"Am J Cardiovasc Drugs"},{"key":"B17","first-page":"100","article-title":"The impact of optimal medical therapy at discharge on mortality in patients with coronary artery disease","volume":"14","author":"Chen","year":"2017","journal-title":"J Geriatr Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.ahj.2007.07.040","article-title":"Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome","volume":"154","author":"Yan","year":"2007","journal-title":"Am Heart J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/0003319710394163","article-title":"Medication use pattern and predictors of optimal therapy at discharge in 8176 patients with acute coronary syndrome from 6 middle eastern countries: data from the gulf registry of acute coronary events","volume":"62","author":"Al-Zakwani","year":"2011","journal-title":"Angiology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1136\/heartjnl-2013-305296","article-title":"Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand","volume":"100","author":"Redfern","year":"2014","journal-title":"Heart"},{"key":"B21","first-page":"167","article-title":"Optimal medical therapy for secondary prevention after an acute coronary syndrome: 18-month follow-up results at a tertiary teaching hospital in South Korea","volume":"12","author":"Byeon","year":"2016","journal-title":"Ther Clin Risk Manag"},{"article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines [Internet]","year":"","author":"Hickman","key":"B22"},{"key":"B23","first-page":"e18","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"B24","first-page":"200162","article-title":"Optimal medical therapy after percutaneous coronary intervention in very elderly patients with coronary artery disease","volume":"16","author":"Nakamura","year":"2022","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa2407791","article-title":"Invasive treatment strategy for older patients with myocardial infarction","volume":"391","author":"Kunadian","year":"2024","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCULATIONAHA.115.021183","article-title":"Coronary artery bypass graft versus percutaneous coronary intervention","volume":"134","author":"Kurlansky","year":"2016","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/MLR.0b013e3182a3e525","article-title":"Reasons for not prescribing guideline-recommended medications to adults with heart failure","volume":"51","author":"Steinman","year":"2013","journal-title":"Med Care"},{"key":"B28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jjcc.2020.12.015","article-title":"Trends in optimal medical therapy at discharge and clinical outcomes in patients with acute coronary syndrome in Thailand","volume":"77","author":"Wongsalap","year":"2021","journal-title":"J Cardiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jacc.2023.03.430","article-title":"Implementing guideline-directed medical therapy for heart failure: jACC focus seminar 1\/3","volume":"82","author":"Patolia","year":"2023","journal-title":"J Am Coll Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1522216\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:06:57Z","timestamp":1758719217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1522216\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":29,"alternative-id":["10.3389\/fcvm.2025.1522216"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1522216","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"article-number":"1522216"}}